Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, April 20, 2018 · 443,106,794 Articles · 3+ Million Readers

Mammography Screening population in United States will increase to more than 50 Million by 2022

Breast Cancer Screening Market in United States worth US$ 5.8 Billion by 2022

PUNE, MAHARASHTRA, INDIA, October 24, 2017 /EINPresswire.com/ -- Breast cancer is the most commonly diagnosed cancer among American women. In 2017, it's estimated that about 30% of newly diagnosed cancers in women will be breast cancers. Breast cancer death rates are higher for women in the US than those for any other cancer, besides lung cancer.

Increasing incidence of breast cancer cases in United States is the major factor for growth in breast cancer screening market in United States

Other factors include:
•Increasing awareness related to early breast cancer detection (First Breast Cancer Awareness Month was observed in the United States in the month of October)

•Growing government investments and funding for breast cancer screening (Breast Cancer Awareness Month is as much about raising funds for breast cancer research and support, as it is about raising awareness)

•Technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

Take a look at the sample to check the key topics covered in this research study.
https://www.precisemarketreports.com/report/sample/pmr-17434

Breast Cancer Awareness Month: A key opportunity to inform women of the need for personalized breast care. (GE Healthcare)

Leading players in the Breast Cancer Screening Market like GE Healthcare, Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation commitment to personalized breast care continues to grow through innovation and adaptability.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market.

Long-term Growth Projection:
Mammography grasp the dominant share in the United States Breast Cancer Screening Market

•Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022

•Number of mammography screening population in United States will increase to more than 50 Million by 2022

Purchase the study to check Breast Cancer Screening Market Clinical Trial Insight by Phase, Company & Country:
https://www.precisemarketreports.com/paypal/checkout/pmr-17434

For more detailed overview of this report, contact Precise Market Reports

Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.

Parag Pingale
Precise Market Reports
+1323744-6588
email us here

Powered by EIN Presswire